In the context of infectious diseases like COVID-19, vitamin K inhibits pro-inflammatory cytokines (IL-6, IL-1β, and TNF-α) and enhances the integrity of alveolar-capillary membranes reducing the risk of acute respiratory distress syndrome (ARDS) (37). The gene discussed is IL1B; the disease is acute respiratory distress syndrome.